BMJ 1994;308:1459-1462 (4 June)

Papers

Antenatal screening for cystic fibrosis: a trial of the couple model

J Livingstone, R A Axton, A Gilfillan, M Mennie, M Compton, W A Liston, A A Calder, A J Gordon, D J H Brock 

Human Genetics Unit, University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU Department of Obstetrics and Gynaecology, University of Edinburgh, Edinburgh EH3 9EW Correspondence to: Professor Brock.

Abstract

Objective : To assess the delivery and acceptability of antenatal couple screening for cystic fibrosis. Carrier status was notified only when both members of a partnership had cystic fibrosis alleles and therefore a one in four risk of having an affected child.
Design : Mouthwash samples were tested when both partners participated. Results were returned only to positive couples.
Setting : Two large maternity hospitals in Edinburgh.
Subjects : Screening was offered to all couples who booked at one of the two hospitals.
Main outcome measures : (a) The take up of screening, carriers and carrier couples identified, take up of prenatal diagnosis, and numbers of affected fetuses detected; (b) questionnaire measures of patient satisfaction and stress.
Results : Screening was offered to 8536 couples. 714 (8.4%) were regarded as ineligible, usually because of late booking or absence of a partner. 1900 (24.3%) of the remainder declined screening. Among the 5922 screened couples, four tested positive - that is, both partners were cystic fibrosis heterozygotes. All four elected to have prenatal diagnosis. There were three terminations of pregnancy because of an affected fetus, one couple having two successive pregnancies with affected fetuses. The participation rate was 76% for eligible couples (5922/7822) and 69% for all couples (5922/8536). Only 89 screened couples (1.5%) requested information on individual carrier status. No anxiety was detected among a cohort of the screened population, and 99% of questioned participants expressed satisfaction with the concept of couple screening.
Conclusions : Antenatal couple screening is a20satisfactory and acceptable way of screening for cystic fibrosis and has been adopted as routine in the two trial hospitals.

Clinical implications

  • Clinical implications

  • The participation rate in an antenatal couple screening trial for cystic fibrosis is about 69%

  • Some 24% of couples may decline the offer of screening

  • All positive couples may be expected to accept the offer of prenatal diagnosis

  • Around 1.5% of couples may request information on individual carrier status

  • In this series no anxiety was detected among a representative cohort of the screened population


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

Screening for cystic fibrosis Screening before pregnancy is preferred
J D A Cooper, A J Franks, D J H Brock, and N Quereshi
BMJ 1994 309: 339-340. [Extract] [Full Text]

This article has been cited by other articles:

  • Henneman, L, ten Kate, L P (2002). Preconceptional couple screening for cystic fibrosis carrier status: couples prefer full disclosure of test results. J. Med. Genet. 39: e26-26 [Full text]  
  • Cunningham, S., Marshall, T. (1998). Influence of five years of antenatal screening on the paediatric cystic fibrosis population in one region. Arch. Dis. Child. 78: 345-348 [Abstract] [Full text]  
  • De Braekeleer, M. (1996). Prenatal screening for carriers of cystic fibrosis should screen both partners individually. BMJ 313: 820b-821 [Full text]  
  • Brock, D. J H (1996). Cost effectiveness of antenatal screening for cystic fibrosis. BMJ 312: 908a-908 [Full text]  
  • Cuckle, H S, Richardson, G A, Sheldon, T A, Quirke, P (1995). Cost effectiveness of antenatal screening for cystic fibrosis. BMJ 311: 1460-1460 [Abstract] [Full text]  
  • Boulton, M., Williamson, R. (1995). General practice and new genetics: what do general practitioners know about community carrier screening for cystic fibrosis?. Public Understanding of Science 4: 255-267 [Abstract]  
  • Miedzybrodzka, Z. H, Hall, M. H, Mollison, J., Templeton, A., Russell, I. T, Dean, J. C S, Kelly, K. F, Marteau, T. M, Haites, N. E (1995). Antenatal screening for carriers of cystic fibrosis: randomised trial of stepwise v couple screening. BMJ 310: 353-357 [Abstract] [Full text]  
  • Cooper, J D A, Franks, A J, Brock, D J H, Quereshi, N (1994). Screening for cystic fibrosis Screening before pregnancy is preferred. BMJ 309: 339-340 [Full text]  
  • (1994). SCREENING FOR CYSTIC FIBROSIS ASSESSED. JWatch General 1994: 1-1 [Full text]  
  • Raeburn, S (1994). Screening for carriers of cystic fibrosis. BMJ 308: 1451-1452 [Full text]  



Access jobs at BMJ Careers
Whats new online at Student 

BMJ